SchreinerG.E.Uremia. In: Textbook of
Nephrology, ed. MassryS.G., and
GlassockRJ. Williams &
Wilkins, Baltimore/London.
1983; 4.52–4.58.
2.
Charles O'NeillW.The new nephrologist. Am J Kidney
Dis2000; 5:
978–97.
3.
SierakowskiR., FinlaysonB., LandesR.R., FinlaysonC.D., SierakowskiN.The frequency of urolithiasis in hospital discharge diagnoses in
the United States. Invest Urol1978; 15:
438–41.
4.
SerioA., FraioliA.Epidemiology of Nephrolithiasis.
Nephron1999; 81(suppl):
S26–30.
5.
YoshidaO., TeraiA., OhkawaT., OkadaY.National trend of the incidence of urolithiasis in Japan from
1965 to 1995. Kidney Int.
6.
TrinchieriA.Epidemiology of Urolithiasis. Arch It
Urol1996; 68:
203–49.
7.
BorghiL., FerrettiP., EliaG.F.Epidemiological study of urinary tract stones in a northern
Italian city. Brit J Urol1990; 65:
231–5.
8.
DesnosE.The history of urology to the ninenteenth
century. In: The History of Urology,
MurphyLJT, edt, Thomas
Springfield,
Illinois1972.
9.
HesseA., SienerR.Current aspects of epidemiology and nutrition in urinary stone
disease. World J Urol1997, 15:
165–71.
10.
StreemS.B.Long-term incidence and risks factors for recurrent stones
following percutaneous nephrostolithotomy or percutaneous
nephrostolithotomy/extracorporeal shock wave lithotripy for infection
related calculi. J Urol1995; 153:
584–7.
11.
SunB.Y.C., LeeY.H., JiaanB.P., ChenK.K., ChangL.S., ChenK.T.Recurrence rate and risk factors of urinary calculi after
extracorporeal shock wave lithotripsy. J
Urol1996; 156:
903–6.
12.
KamihiaraO., OnoY., KatohN., YamadaS., MizutaniK., OhshimaS.Long-term stone recurrence rate after extracorporeal shock wave
lithotripsy. J Urol1996; 156:
1267–371.
LechevallierE., SilesS., OrtegaJ.C., CoulangeC.Comparison by SPECT of renal scars after extracorporeal shock
wave lithotripsy and percutaneous nephrolithotomy. J
Endourol1993; 7:
465–7.
15.
WilliamsC.M., ThomasW.C.Permanently decreased renal blood flow and hypertension after
lithotripsy. N Eng J Med1989; 321:
1269–70.
16.
GambaroG., FavaroS., D'AngeloA.Risk of renal failure in Nephrolithiasis.
Am J Kidney Dis2001; 37:
233–43.
17.
SaklayenM.G.Medical management of nephrolithiasis.
Med Clin North Am1997; 81:
785–99.
18.
GibneyE.M., GoldfarbD.S.The association of nephrolithiasis with cystic
fibrosis. Am J Kidney Dis2003; 42:
1–11.
19.
ShekarrizB., StollerM.L.Uric acid nephrolithiasis: current concepts and
controversies. J Urol2002; 168:
1307–14.
20.
StewartC.S., DuncanS.H., CaveD.R.Oxalobacter formigenes and its role in oxalate metabolism in the
human gut. FEMS Microbiol Letters2004; 230:
1–7.
21.
ScheinmanS.J.Nephrolithiasis. Seminars in
Nephrol1999; 19:
381–8.
22.
CurhanG.C., WilletW.C., RimmE.B., StampferM.J.Family history and risk of kidney stones.
J Am Soc Nephrol1997; 8:
1568–73.
23.
ThakkerR.V.Pathogenesis of Dent's disease and related syndromes of X-linked
nephrolithiasis. Kidney Int2000; 57:
787–93.
24.
YagisawaT., KobayashiC., HayashiT., YoshidaA., TomaH.Contributory metabolic factors in the development of
nephrolithiasis in patients with medullary sponge kidney.
Am J Kidney Dis2001; 37:
1140–3.
25.
TislerA., PierratosA., HoneyJ D'Arcy, BullS.B., LoganA.G.Hypertension aggregates in families of kidney stone patients with
high urinary excretion of uric acid. J
Hypertens1999; 17:
1853–8.
26.
MadoreF., StampferM.J., WilletW.C., SpeizerF.E., CrhanG.C.Nephrolithiasis and risk of hypertension in
women. Am J Kidney Dis1998; 32:
802–7.
27.
BorghiL., MeschiT., GuerraA., BrigantiA., ScianchiT., AllegriF., NovariniA.Essential arterial hypertension and stone
disease.
28.
CurhanG.C., WilletW.C., RimmE.B., SpeizerF.E., StampferM.J.Body size and risk of kidney stones. J Am
Soc Nephrol1998; 9:
1645–52.
29.
SchwilleP.O., SchmiedlA., HerrmannU., WipplingerJ.Postprandial hyperinsulinemia, insulin resistance and
inappropriately high phosphaturia are features of younger males with
idiopathic calcium urolithiasis: attenuation by ascorbic acid
supplementation of a test meal. Urol Res1997; 25:
49–58.
30.
PragaM., AlegreR., HernandezE., MoralesE., Dominguez-GilB., CarenoA., AndresA.Familial microscopic ematuria caused by hypercalciuria and
hyperuricosuria. Am J Kidney Dis2000; 35:
141–5.
31.
MessaP., MoniG.L'ipercalciuria a digiuno: teorie e mode.
Giorn Ital Nefrol1985; 2:
147–52.
32.
MessaP., MoniG., MontanaroD.About a primitive osseous origin of the so-called renal
hypercalciuria. Contr Nephrol1987; 58:
106–10.
33.
BatailleP., AchardJ.M., FournierA.Diet, vitamin D and vertebral mineral density in hypercalciuric
calcium stone fromers. Kidney Int1991; 39:
1193–205.
34.
CurhanG.C., WilletW.C., RimmE.B., StampferM.J.A prospective study of dietary calcium and other nutrients and
the risk of symptomatic kidney stones. N Eng J
Med1993; 328:
833–8.
35.
MessaP., MarangellaM., PaganinL.Different dietary calcium intake and relative supersaturation of
calcium oxalate in the urine of patients forming renal
stones. Clin Sci1997; 93:
257–63.
36.
MeltonL.J., CrowsonC.S., KhoslaS., WilsonD.M., O'FallonW.M.Fracture risk among patients with urolithiasis: a
population-based cohort study. Kidney Int1998; 53:
459–64.
LingemanJ., MardisH., KahnoskiR.Medical reduction of stone risk in a network of treatment centers
compared to a research clinic. J Urol1998; 160:
1629–34.
42.
BihlG., MeyersA.Recurrent renal stone disease-advances in pathogenesis and
treatment. Lancet2001; 358:
651–6.
43.
ParksJ.H., CoeF.L.The financial effects of kidney stone prevention.
Kidney Int1996; 50:
1706–12.
44.
ParksJ.H., CoeF.L.An increasing number of calcium oxalate stone events worsens
treatment outcome. Kidney Int1994; 45:
1722–30.
45.
LevyF.L., Adams-HuetB., PakC.Y.C.Ambulatory evaluation of nephrolithiasis: an update of a 1980
protocol. Am J Med1995; 98:
50–9.
